AeroDel Technology Innovations Pvt. Ltd., a Mumbai-based respiratory medical device company, announces an exclusive licensing arrangement with Zydus Lifesciences Limited for the commercial pan-India ...
Une femme enceinte asthmatique doit bénéficier d’une prise en charge thérapeutiCorticosteroids and short-acting beta agonists remain the core therapies for pregnant patients with asthma.
Advent Therapeutics is developing vitamin A therapies aimed at preventing chronic lung disease in premature babies.
There are a lot of emerging technologies at SXSW — AI voice restoration, robotaxis, XR experiences. But there's only one ...
A firefighter fell through the first floor into the basement and a mayday was called, Nolan said. The firefighter was able to get out of the building on their own and uninjured. Fire crews searched ...
London's mayor and medical officer of health are voicing their support for bringing an inhalation centre to London, joining ...
Approval marks the second regulatory approval outside of the U.S. Food and Drug Administration, further expanding access to COPD patients in select Special Administrative Regions (SARs) in Greater Chi ...
In idiopathic pulmonary fibrosis (IPF), the trajectory of declining lung function and clinical worsening was less drastic with the use of inhaled treprostinil (Tyvaso), the placeb ...
GH Research PLC is rated a Buy with $280.7M in cash, supporting lead candidate GH001 for Treatment-Resistant Depression. Read more on GHRS stock here.
Appointment adds extensive commercial, operational, and strategic leadership experience as Avalyn advances its pipeline of inhaled therapies for pulmonary fibrosis ...
Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S.
Sometimes the story can be told in statistics. India accounts for 13% of the global population, yet it accounts for 42% of global asthma mortality. Around 35 million Indians are thought to be living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results